Horm Metab Res 2003; 35(3): 142-146
DOI: 10.1055/s-2003-39074
Original Basic
© Georg Thieme Verlag Stuttgart · New York

Estrogen Reduces Pro-Inflammatory Cytokines in Rodent Adipose Tissue: Studies In vivo and In vitro

J.  M.  Bruun 1 , C.  B.  Nielsen 2 , St.  B.  Pedersen 1 , A.  Flyvbjerg 2 , B.  Richelsen 1
  • 1 Department of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus Amtssygehus, Aarhus, Denmark
  • 2 Medical Research Laboratories and Institute of Experimental Clinical Research, Aarhus University Hospital, Aarhus, Denmark
Further Information

Publication History

Received 1 October 2002

Accepted after revision 5 November 2002

Publication Date:
07 May 2003 (online)

Abstract

Obesity is associated with an increased risk of developing insulin resistance, Type 2 diabetes, and cardiovascular disease. Reports have suggested that adipose tissue-derived cytokines such as tumor necrosis factor-α, interleukin-6 and interleukin-8 could be involved in the development of these health complications. Since estrogen has been suggested to attenuate the development of atherosclerosis and cardiovascular disease, we investigated whether ovariectomy affected the production and release of these three adipose tissue-derived cytokines with and without estrogen replacement in vivo and in vitro. Female Wistar rats were submitted to either a) ovariectomy, b) ovariectomy and estrogen replacement, or c) sham operation. After five months, animals were sacrificed and parametrial adipose tissue was removed and incubated for up to 24 hours with either interleukin-1β (IL-1β) (5 µg/l), dexamethasone (50 nM) or estrogen (50 nM). Ovariectomy significantly increased interleukin-6 gene expression (p < 0.05) as well as interleukin-8 protein levels (p < 0.05) and gene expression (p < 0.05) in the adipose tissue, and estrogen replacement significantly reversed this increase (p < 0.05). However, no direct effects of estrogen were found in in vitro adipose tissue incubations. Neither ovariectomy nor estrogen replacement had any effects on tumor necrosis factor-α protein levels or gene expression. In conclusion, estrogen-deficient rats were found to have increased production of interleukin-6 and interleukin-8, which could be attenuated by estrogen-replacement. Since estrogen is suggested to be anti-atherosclerotic, this effect might be caused by a reduction in cytokine production from the adipose tissue.

References

  • 1 Gray J M, Greenwood M R. Time course of effects of ovarian hormones on food intake and metabolism.  Am J Physiol. 1982;  243 E407-E412
  • 2 Jones M E, Thorburn A W, Britt K L, Hewitt K N, Misso M L, Wreford N G, Proietto J, Oz O K, Leury B J, Robertson K M, Yao S, Simpson E R. Aromatase-deficient (ArKO) mice accumulate excess adipose tissue.  J Steroid Biochem Mol Biol. 2001;  79 3-9
  • 3 Heine P A, Taylor J A, Iwamoto G A, Lubahn D B, Cooke P S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice.  Proc Natl Acad Sci USA. 2000;  97 12 729-12 734
  • 4 Gray J M, Dudley S D, Wade G N. In vivo cell nuclear binding of 17 beta-[3H]estradiol in rat adipose tissues.  Am J Physiol. 1981;  240 E43-E46
  • 5 Pedersen S B, Borglum J D, Eriksen E F, Richelsen B. Nuclear estradiol binding in rat adipocytes. Regional variations and regulatory influences of hormones.  Biochim Biophys Acta. 1991;  1093 80-86
  • 6 Pedersen S B, Bruun J M, Hube F, Kristensen K, Hauner H, Richelsen B. Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: influences of adipose cell differentiation and fat depot localization.  Mol Cell Endocrinol. 2001;  182 27-37
  • 7 Kopelman P G. Obesity as a medical problem.  Nature. 2000;  404 635-643
  • 8 Yoshida S, Yamashita S, Tokunaga K, Yamane M, Shinohara E, Keno Y, Nishida M, Kotani K, Shimomura I, Kobayashi H, Nakamura T, Miyagawa J, Kameda-Takemura K, Odaka H, Ikeda H, Matsuzawa Y. Visceral fat accumulation and vascular complications associated with VMH lesioning of spontaneously non-insulin-dependent diabetic GK rat.  PG - Int J Obes Relat Metab Disord. 1996;  20 909-916
  • 9 Lawrence V J, Coppack S W. The endocrine function of the fat cell-regulation by the sympathetic nervous system.  Horm Metab Res. 2000;  32 453-467
  • 10 Hotamisligil G S, Shargill N S, Spiegelman B M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.  Science. 1993;  259 87-91
  • 11 Gimble J M, Dorheim M A, Cheng Q, Medina K, Wang C S, Jones R, Koren E, Pietrangeli C, Kincade P W. Adipogenesis in a murine bone marrow stromal cell line capable of supporting B lineage lymphocyte growth and proliferation: biochemical and molecular characterization.  Eur J Immunol. 1990;  20 379-387
  • 12 Stephens J M, Butts M D, Pekala P H. Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-alpha.  J Mol Endocrinol. 1992;  9 61-72
  • 13 Bruun J M, Pedersen S B, Richelsen B. Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro.  J Clin Endocrinol Metab. 2001;  86 1267-1273
  • 14 Gerhardt C C, Romero I A, Cancello R, Camoin L, Strosberg A D. Chemokines control fat accumulation and leptin secretion by cultured human adipocytes.  Mol Cell Endocrinol. 2001;  175 81-92
  • 15 Kern P A, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.  Am J Physiol Endocrinol Metab. 2001;  280 E745-E751
  • 16 Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen P T, Kaartinen M, Nussberger J, Harringer W, Drexler H. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability.  Circulation. 2000;  101 1372-1378
  • 17 Boisvert W A, Curtiss L K, Terkeltaub R A. Interleukin-8 and its receptor CXCR2 in atherosclerosis [In Process Citation].  Immunol Res. 2000;  21 129-137
  • 18 Karas R H. Animal models of the cardiovascular effects of exogenous hormones.  Am J Cardiol. 2002;  90 22F-25F
  • 19 Karas R H, Schulten H, Pare G, Aronovitz M J, Ohlsson C, Gustafsson J A, Mendelsohn M E. Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice.  Circ Res. 2001;  89 534-539
  • 20 Walsh B A, Mullick A E, Walzem R L, Rutledge J C. 17beta-estradiol reduces tumor necrosis factor-alpha-mediated LDL accumulation in the artery wall.  J Lipid Res. 1999;  40 387-396
  • 21 Sukovich D A, Kauser K, Shirley F D, DelVecchio V, Halks-Miller M, Rubanyi G M. Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice: inhibition by 17beta-estradiol.  Arterioscler Thromb Vasc Biol. 1998;  18 1498-1505
  • 22 Rutter K, Hennoste L, Ward L C, Cornish B H, Thomas B J. Bioelectrical impedance analysis for the estimation of body composition in rats.  Lab Anim. 1998;  32 65-71
  • 23 Kristensen K, Pedersen S B, Richelsen B. Regulation of leptin by steroid hormones in rat adipose tissue.  Biochem Biophys Res Commun. 1999;  259 624-630
  • 24 Pedersen S B, Bruun J M, Kristensen K, Richelsen B. Regulation of UCP1, UCP2, and UCP3 mRNA expression in brown adipose tissue, white adipose tissue, and skeletal muscle in rats by estrogen.  Biochem Biophys Res Commun. 2001;  288 191-197
  • 25 Fried S K, Bunkin D A, Greenberg A S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid.  J Clin Endocrinol Metab. 1998;  83 847-850
  • 26 Frieri M. Corticosteroid effects on cytokines and chemokines.  Allergy Asthma Proc. 1999;  20 147-159

J. M. Bruun, M.D.

Department of Endocrinology and Metabolism

Aarhus Amtssygehus · Tage Hansensgade 2 · 8000 Aarhus C · Denmark

Fax: + 4589497649

Email: jmb@mail-online.dk

    >